Top Banner
A 30-year male with cognitive decline and unsteady gait Teaching NeuroImages Neurology Resident and Fellow Section © 2013 American Academy of Neurology
4

A 30-year male with cognitive decline and unsteady gait Teaching NeuroImages Neurology Resident and Fellow Section © 2013 American Academy of Neurology.

Jan 14, 2016

Download

Documents

Lawrence Norris
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: A 30-year male with cognitive decline and unsteady gait Teaching NeuroImages Neurology Resident and Fellow Section © 2013 American Academy of Neurology.

A 30-year male with cognitive decline and unsteady gait

Teaching NeuroImages

NeurologyResident and Fellow Section

© 2013 American Academy of Neurology

Page 2: A 30-year male with cognitive decline and unsteady gait Teaching NeuroImages Neurology Resident and Fellow Section © 2013 American Academy of Neurology.

Vignette

• A 30-year old male with history of bipolar disease presented with 6 months of cognitive decline, unsteady gait, urinary retention, and bilateral upper extremity tremors

Ramanathan et al.

Page 3: A 30-year male with cognitive decline and unsteady gait Teaching NeuroImages Neurology Resident and Fellow Section © 2013 American Academy of Neurology.

ImagingA

DC

B

Ramanathan et al.

Page 4: A 30-year male with cognitive decline and unsteady gait Teaching NeuroImages Neurology Resident and Fellow Section © 2013 American Academy of Neurology.

Diffuse Cerebral Neurosarcoidosis mimicking Gliomatosis Cerebri

• Neurosarcoidosis can mimic infection (viral, tuberculosis, or cryptococcus), toxic leukoencephalopathy & malignancies like gliomatosis cerebri or angiocentric lymphoma.

• MRI in neurosarcoidosis often reveals enhancing periventricular white matter lesions, in this case mimicking diffuse gliomatosis cerebri1,2.

• The patient responded well to high dose steroids and intravenous cyclophosphamide.

Ramanathan et al